BILL · 2021–22 SESSION · LATEST VERSION SSB 5983
SB 5983: Cannabinoid products
Concerning cannabinoid products.
Summary
- Adds and amends definitions in the Uniform Controlled Substances Act, including expanding the definition of THC concentration to include all tetrahydrocannabinols (THCs) instead of only referencing delta-9 THC.
- Prohibits the sale of certain cannabinoid products with a THC concentration exceeding 0.3 percent except when sold by licensed cannabis producers, processors, or retailers (cannabis licensees).
- Allows the sale of certain cannabinoid products with a THC concentration of 0.3 percent or less by persons other than cannabis licensees if the product contains a 20:1 ratio of cannabidiol or other non-THC cannabinoid to THC.
- Establishes a scientific panel, contingent on funding, to research information in other jurisdictions relative to cannabinoids and make recommendations to the Legislature by December 1, 2022.
- Directs the Department of Health, contingent on funding, to create a grant program to assist local health departments enforce unauthorized sales of cannabinoid products.
From the Senate Bill Report (SB 5983), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · stalled on the Senate floor
- IntroducedFeb 28, 2022
- Out of committeeMar 8, 2022
- Passed Senatestopped here
- Passed House
- Governor
- Law
- Prime sponsor
- Karen Keiser (D-33)
- Introduced
- February 28, 2022 in the Senate
- Last action
- March 10, 2022
- Budget
- Has a fiscal note
- Versions
- SB 5983, SSB 5983
AN ACT Relating to ensuring consumers have legal access to cannabinoid products that have been tested and that meet standards for quality and safety while preventing intoxicating products from being sold outside of the regulated adult-use cannabis market and establishing a scientific panel to review cannabinoid science;
Sponsors
Prime sponsor: Karen Keiser (D-33)
3 co-sponsors (2 Democrats, 1 Republican)
Votes
No recorded floor votes.
History
- Returned to Rules. (SSB 5983)
- Returned to Rules.
- Placed on second reading by Rules Committee. (SSB 5983)
- Passed to Rules Committee for second reading. (SSB 5983)
- Passed to Rules Committee for second reading.
- Placed on second reading by Rules Committee.
- Minority; without recommendation. (SSB 5983)
- WM - Majority; 1st substitute bill be substituted, do pass. (SSB 5983)
- WM - Majority; 1st substitute bill be substituted, do pass.
- Minority; without recommendation.
- First reading, referred to Ways & Means.
SB 5983 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5983 (2025–26) Current use land/sale to gov
- SB 5983 (2023–24) Syphilis treatment
- SB 5983 (2019–20) LEOFF 2 pension system
- SB 5983 (2017–18) Family and med leave/opt-out
- SB 5983 (2015–16) Ag services for remuneration
- SB 5983 (2013–14) Wells/gr mgmt hearings brds
- SB 5983 (2011–12) Aerospace B&O tax credit
- SB 5983 (2009–10) Scope of agency actions